Ascend Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-39,210
| Closed | -$5.5M | – | 264 |
|
|
2017
Q3 | $5.5M | Buy |
+39,210
| New | +$5.5M | 0.21% | 105 |
|
|
2017
Q2 | – | Sell |
-123,755
| Closed | -$15M | – | 198 |
|
|
2017
Q1 | $15M | Buy |
+123,755
| New | +$15M | 0.68% | 54 |
|
|
2016
Q3 | – | Sell |
-209,011
| Closed | -$24.4M | – | 176 |
|
|
2016
Q2 | $24.4M | Buy |
+209,011
| New | +$24.4M | 1.6% | 15 |
|
|
2016
Q1 | – | Sell |
-11,636
| Closed | -$2.22M | – | 160 |
|
|
2015
Q4 | $2.22M | Sell |
11,636
-13,738
| -54% | -$2.62M | 0.08% | 123 |
|
|
2015
Q3 | $3.97M | Sell |
25,374
-145,322
| -85% | -$22.7M | 0.16% | 92 |
|
|
2015
Q2 | $30.9M | Buy |
170,696
+29,962
| +21% | +$5.42M | 1.02% | 34 |
|
|
2015
Q1 | $24.4M | Buy |
+140,734
| New | +$24.4M | 0.84% | 40 |
|